Home / Stocks / ABT

Abbott Laboratories (ABT, Health Care Equipment) Stock Valuation & Fair Value Trading above fair value

Abbott Laboratories (ABT, Health Care Equipment) trades at a blended P/E of 21.2, about 5% above its historical normal valuation, with a forward growth estimate of 9.9% and a PEG of 2.15. Analysts' one-year estimates have been hit 82% of the time.

DATA AS OF 2026-08-21
Blended P/E
21.2
Normal P/E
20.2
PEG
2.15
Fwd growth
9.9%
Div yield
2.2%
RSI (14)
73.3
Overbought

The Street vs SeerForecast

Wall Street's mean price target for ABT is $119.40 across 25 analysts, 2.4% above the current price. The average analyst rating is Buy. Our SeerForecast read of the same stock, formed without analyst targets: trading above fair value. When the two disagree, start your digging there.

Valuation flags

Verdict history

tickerseer's rating moved from fairly valued (2026-06-03) to trading above fair value (2026-08-21).

Price and rating by weekClose moved +28.8 percent from 2026-06-03 to 2026-08-17, with 3 rating changes over 21 recorded weeks.2026-06-03: Fairly valued, close 86.37 (recalculated)2026-06-10: Fairly valued, close 88.54 (recalculated)2026-06-14: Fairly valued, close 87.56 (recalculated)2026-06-16: Fairly valued, close 89.98 (recalculated)2026-06-21: Fairly valued, close 87.78 (recalculated)2026-07-02: Fairly valued, close 94.72 (recalculated)2026-07-06: Fairly valued, close 94.95 (recalculated)2026-07-09: Fairly valued, close 93.73 (recalculated)2026-07-12: Fairly valued, close 93.26 (recalculated)2026-07-13: Fairly valued, close 91.46 (recalculated)2026-07-14: Fairly valued, close 88.33 (recalculated)2026-07-20: Fairly valued, close 101.66 (recalculated)2026-07-22: Fairly valued, close 100.57 (recalculated)2026-07-25: Fairly valued, close 103.06 (recalculated)2026-07-27: Fairly valued, close 104.49 (recalculated)2026-07-31: Fairly valued, close 105.70 (recalculated)2026-08-03: Fairly valued, close 105.702026-08-07: Trading above fair value, close 107.81 (recalculated)2026-08-10: Fairly valued, close 107.812026-08-14: Trading above fair value, close 111.25 (recalculated)2026-08-17: Trading above fair value, close 111.25861112026-06-032026-08-17
Attractively valuedFairly valuedAbove fair valueLarger dot: a stronger reading

Not every point was recorded live. Points marked recalculated apply today's valuation rules to the metrics tickerseer archived that week.

2026-06-03P/E 16.3-19%Fairly valued
2026-06-10P/E 17.2-15%Fairly valued
2026-06-14P/E 17.2-15%Fairly valued
2026-06-16P/E 17.2-15%Fairly valued
2026-06-21P/E 17.2-15%Fairly valued
2026-07-02P/E 17.4-14%Fairly valued
2026-07-06P/E 17.9-11%Fairly valued
2026-07-09P/E 17.9-11%Fairly valued
2026-07-12P/E 17.6-12%Fairly valued
2026-07-13P/E 17.6-12%Fairly valued
2026-07-14P/E 17.6-12%Fairly valued
2026-07-20P/E 18.8-7%Fairly valued
2026-07-22P/E 18.8-7%Fairly valued
2026-07-25P/E 19.2-5%Fairly valued
2026-07-27P/E 19.2-5%Fairly valued
2026-07-31P/E 19.7-2%Fairly valued
2026-08-03P/E 19.7-2%Fairly valued
2026-08-07P/E 20.1-0%Trading above fair value
2026-08-10P/E 20.1-0%Fairly valued
2026-08-14P/E 20.7+3%Trading above fair value
2026-08-17P/E 20.7+3%Trading above fair value
2026-08-21P/E 21.2+5%Trading above fair value ← now

Frequently asked questions

Is Abbott Laboratories stock overvalued?

At a blended P/E of 21.2 versus its historical normal P/E of 20.2, Abbott Laboratories trades about 5% above its typical valuation, with a PEG of 2.15 on 9.9% forward growth. tickerseer currently rates it trading above fair value.

What is Abbott Laboratories's fair value and PEG?

Abbott Laboratories trades at a blended P/E of 21.2 against a historical normal P/E of 20.2, a PEG of 2.15, and a forward growth estimate of 9.9%.

Has tickerseer's rating of Abbott Laboratories changed?

tickerseer's rating moved from fairly valued (2026-06-03) to trading above fair value (2026-08-21).

What is the analyst price target for Abbott Laboratories?

The mean Wall Street price target for Abbott Laboratories is $119.40 across 25 analysts, 2.4% above the current price. tickerseer's SeerForecast verdict is formed independently of analyst targets.

Industry: Health Care Equipment. Create a free account to see the full analysis: the SeerAI score, its five quality sub-scores, valuation history, and the AI research note. Options setups and metric history are part of the paid plans.

See the full analysis →🔔 Track ABT free: valuation & earnings alerts

Get the free weekly earnings preview

One email each Monday with the week's named earnings setups, the reasoning, and what settled last week. Strikes and sizing stay in Premium.

It's free, and you can unsubscribe any time. Educational content, not investment advice.